Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis

Lin He,1,* Qian Wu,1,* Jing Xiong,2 Zhumin Su,3 Biyuan Zhang,4 Yuhua Song11Breast Center B Ward, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People’s Republic of China; 2Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandon...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: He L, Wu Q, Xiong J, Su Z, Zhang B, Song Y
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Assuntos:
human epidermal growth factor receptor 2
trastuzumab
mastectomy
breast conserving therapy
breast cancer.
Acceso en liña:https://www.dovepress.com/do-early-her2-overexpression-breast-cancer-patients-benefit-from-under-peer-reviewed-article-CMAR
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares